MarketBeat
12 Jun 2026, 13:41 UTC · 19w ago
Impact · against what's priced in
The news is overwhelmingly negative for SMX as it highlights a catastrophic lack of commercial traction and critical liquidity risks. While SpaceX is presented as a success story in its sector, SMX is positioned as a binary bet with severe fundamental deterioration and a ticking clock on its solvency.
No priced-in read yet
What the story claims
6 claims · scored −1 bearish … +1 bullish
SMX has reported zero revenue in all SEC filings to date despite being a 10-year-old company.
More negative than 99% of claims this week
SMX's current ratio is 0.59, meaning current liabilities exceed current assets.
So whatPoor liquidity suggests a high risk of insolvency or the need for imminent, highly dilutive capital raises.
Continue reading
5 related stories
A 10-year-old company with zero revenue, a current ratio of 0.59, and a 90% drop in shareholder equity indicates severe failure in commercialization and an imminent risk of insolvency.
Read from the article alone
No priced-in read yet
The company's IPO is described as captivating investors and delivering on the promise of the space sector.
Read from the article alone
No priced-in read yet
Unlike SMX, Applied DNA Sciences already has a similar molecular tagging platform with paying customers in the textile industry.
Read from the article alone
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 99% of claims this week
Shareholder equity fell approximately 90% between FY2023 and mid-2025.
More negative than 98% of claims this week
Approximately 63% of SMX's float was sold short as of May 29.
So whatHigh short interest signals strong professional skepticism, though it introduces short-squeeze volatility.
More negative than 86% of claims this week
Which stocks this story touches
More positive than 90% of ticker scores this week
The article describes the company as captivating investors and delivering on its promise.
More negative than 79% of ticker scores this week
Despite novel technology, the company has zero revenue, mounting losses, high short interest, and a 'Sell' rating.
More positive than 62% of ticker scores this week
Mentioned as a competitor with a similar platform that already has paying customers.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
7h ago
−87.4%
Price agrees with the score
$1.75 vs $13.91 close before publication (Jun 11) · not market-adjusted
SMX chart →—
No price for SPCX right now — the quote feed didn't answer.
SPCX chart →—
No price for APDN right now — the quote feed didn't answer.
APDN chart →
